腺伴随病毒载体介导帕金森病基因治疗的实验研究
被引量：1
出处
《中华老年医学杂志》
CAS
CSCD
北大核心
2001年第4期303-304,共2页
Chinese Journal of Geriatrics
基金
国家"8 6 3"重大项目基金 (Z2 0 0 4 0 3)
教育部回国留学人员启动基金资助
参考文献1
-
1Fan D S，Human Gene Therapy，1998年，9卷，2527页
同被引文献12
-
1[4]Fan DS, Ogawa M, Fujimoto KI, et al. Behavioral recovery in 6-hydroxydopaminelesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum Geae Ther 1998; 9:2527 - 35
-
2[5]Langston JW, Quik M, Petzinger G, et al. Investigating levodopa-induced dyskinesias in the parkinsonian primate. Ann Neurol 2000; 47:S79 - S89
-
3[8]Carey RJ, Pinheiro-Carrera M, Dai H, et al. L-Dopa and psychosis: Evidence for L-Dopa-induced increases in prefrontal cortex dopamine and in serum corticosterone. Biol Psychiatry 1995; 8:669 - 6
-
4[9]Monahan PE, Samulski RJ. AAV vectors: Is clinical success on the horizon? Gene Ther 2000; 7:24 - 30
-
5[10]Elsworth JD, Taylor JR, Sladek JR, et al. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in Old-World primates one year after MPTP treatment. Neuroscience 2000; 95:399 - 408
-
6[11]Parent A, Hazrati LN. Functional anatomy of the basal ganglia. The corticobasal ganglia-thalamo-cortical loop. Brain Res Rev 1995; 20:91 - 127
-
7[12]Mandel RJ, Renddhl KG, Spratt SK, et al. Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson' s disease. J Neuroscience 1998; 18:4271 - 84
-
8[13]During MJ, Samulski RJ, Elsworth JD, et al. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther 1998;5:820 -27
-
9沈扬,樊东升,王立军,康德瑄,中野今治,小泽敬也,永津俊治.帕金森病大鼠三重目的基因共表达的长期行为改善[J].中华神经科杂志,2002,35(1):16-18. 被引量：3
-
10孔岳南,谢惠君.多巴胺系统基因和帕金森病的相关性[J].中国临床康复,2003,7(19):2730-2731. 被引量：25
-
1周国庆,周孝达,陈生弟.帕金森病基因治疗的实验研究[J].中风与神经疾病杂志,1997,14(5):314-316.
-
2姚尧,杜俊蓉.帕金森病基因治疗中病毒载体的研究进展[J].华西医学,2005,20(4):797-798.
-
3王应莉,邓兴力.帕金森病基因治疗研究进展[J].中华老年医学杂志,2013,32(11):1261-1264. 被引量：1
-
4欧阳佳,武广永,刘如恩.帕金森病基因治疗研究进展[J].中国临床神经外科杂志,2015,20(3):187-189. 被引量：1
-
5田华,田有勇,孙圣刚.帕金森病基因治疗研究现状[J].临床内科杂志,2007,24(6):375-378. 被引量：1
-
6徐强.帕金森病基因治疗实验研究进展[J].国外医学（神经病学．神经外科学分册）,1999,26(6):317-320. 被引量：2
-
7陈先文,陈生弟.帕金森病基因治疗研究若干问题的思考[J].医学与哲学,1999,20(2):42-44. 被引量：2
-
8刘菲,王思,李秀华,贾军.帕金森病基因治疗的研究进展[J].国际神经病学神经外科学杂志,2014,41(4):352-355.
-
9樊东升,沈扬,康德宣.Adeno-associated virus vector-mediated triple gene transfer of dopamine synthetic enzymes[J].Chinese Medical Journal,2001(12):44-47.
-
10刘会霞,徐国桓,张世红,龚文涛.帕金森病基因治疗文献调查分析[J].医学理论与实践,2000,13(6):382-383.
